| Dr Anne Herron, MD | |
|
222 S Woods Mill Rd, Suite 750, Chesterfield, MO 63017-3625 | |
| (314) 205-6600 | |
| (314) 434-5939 |
| Full Name | Dr Anne Herron |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Rheumatology |
| Location | 222 S Woods Mill Rd, Chesterfield, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073628715 | NPI | - | NPPES |
| P00092814 | Other | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 35815 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anne Herron, MD 222 S Woods Mill Rd, Suite 750, Chesterfield, MO 63017-3625 Ph: (314) 205-6600 | Dr Anne Herron, MD 222 S Woods Mill Rd, Suite 750, Chesterfield, MO 63017-3625 Ph: (314) 205-6600 |
News Archive
Survival rates overall for childhood cancer are almost 80 percent—a marked advance against a disease that was curable in only a small fraction of children 50 years ago. However, despite progress, pediatric cancer remains the leading cause of death due to disease among U.S. children older than 1 year of age.
A new Tel Aviv University study finds that combining genetic therapy with chemotherapy delivered to a primary tumor site is extremely effective in preventing breast cancer metastasis.
Home visits by a cardiac surgery nurse practitioner (NP) following coronary artery bypass grafting (CABG) surgery can dramatically reduce a patient's risk of hospital readmission and death 30 days after surgery, according to a study in the May 2014 issue of The Annals of Thoracic Surgery.
Diabetes affects more than 400 million people worldwide and is a major public health problem. Although commonly referred to as a single disease, it actually constitutes a group of metabolic disorders with hyperglycemia as a common feature. Of all its forms, monogenic diabetes - due to a mutation in one of the genes involved in the management of blood sugar levels - affects 1% to 4% of all cases of diabetes.
Teikoku Pharma USA, Inc. announced today that the U.S. Food and Drug Administration has approved Docetaxel Injection, Non-Alcohol Formula ("Docetaxel Injection") for the treatment of breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, and head and neck cancer.
› Verified 8 days ago
Lovepreet Singh Randhawa, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 224 S Woods Mill Rd, Chesterfield, MO 63017 Phone: 314-205-6050 Fax: 314-205-6350 | |
Rachel Lynn Fishman Oiknine, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 222 S Woods Mill Rd, Suite 410n, Chesterfield, MO 63017 Phone: 314-469-6224 Fax: 314-469-0744 | |
Xiaoling Wu, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 224 S Woods Mill Rd, Suite 370 South, Chesterfield, MO 63017 Phone: 314-878-2460 | |
Daniel B Bauwens, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 232 S Woods Mill Rd, Chesterfield, MO 63017 Phone: 314-576-5023 | |
Michael Carl Fusco, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 14528 S Outer 40, Suite 300, Chesterfield, MO 63017 Phone: 314-214-8100 Fax: 314-214-8233 | |
David H Cort, M.D. Rheumatology Medicare: Medicare Enrolled Practice Location: 226 S Woods Mill Rd, Suite 52 West, Chesterfield, MO 63017 Phone: 314-434-2399 Fax: 314-434-5653 | |
Meghashyam Jayateerth Koti, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 15740 S Outer 40 Rd # C, Chesterfield, MO 63017 Phone: 636-735-4963 |